Sidse Ehmsen
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 10
- Cancer-related Molecular Pathways 5
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Henrik J. Ditzel (16 shared papers)Mikkel G. Terp (6 shared papers)Rikke Leth‐Larsen (5 shared papers)Brian L. Hood (2 shared papers)Martin H. Pedersen (2 shared papers)Thomas P. Conrads (2 shared papers)Guisong Wang (1 shared paper)Martin Bak (6 shared papers)
- Journals
- Nature Communications (4 papers)International Journal of Cancer (3 papers)Stem Cells (2 papers)Frontiers in Oncology (1 paper)Molecular Oncology (1 paper)
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
Sidse Ehmsen
20 papers receiving 754 citations
Sidse Ehmsen's Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 311
- Oncology 289
- Immunology 182
- Pulmonary and Respiratory Medicine 189
- Molecular Biology 348
Countries citing papers authored by Sidse Ehmsen
This map shows the geographic impact of Sidse Ehmsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidse Ehmsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidse Ehmsen more than expected).
Fields of papers citing papers by Sidse Ehmsen
This network shows the impact of papers produced by Sidse Ehmsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidse Ehmsen. The network helps show where Sidse Ehmsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Sidse Ehmsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation Hit paper breakdown → | 2023 | 148 |
| 2 | 2019 | 139 | |
| 3 | 2022 | 116 | |
| 4 | 2021 | 56 | |
| 5 | 2018 | 52 | |
| 6 | 2022 | 47 | |
| 7 | 2011 | 37 | |
| 8 | 2020 | 35 | |
| 9 | 2020 | 30 | |
| 10 | 2021 | 25 | |
| 11 | 2018 | 20 | |
| 12 | 2015 | 18 | |
| 13 | 2017 | 12 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2025 | 1 | |
| 19 | 2016 | 1 | |
| 20 | Udfordringer ved kræftbehandling til ældre | 2021 | 1 |
About Sidse Ehmsen
Sidse Ehmsen is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and General Health Professions, having authored 20 papers that have together received 759 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Cancer-related Molecular Pathways (5 papers), Breast Cancer Treatment Studies (3 papers), Cancer, Lipids, and Metabolism (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cell Adhesion Molecules Research (2 papers), Cancer Cells and Metastasis (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (311 citations), Oncology (289 citations), Immunology (182 citations), Pulmonary and Respiratory Medicine (189 citations) and Molecular Biology (348 citations). Sidse Ehmsen has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Henrik J. Ditzel, Mikkel G. Terp, Rikke Leth‐Larsen, Brian L. Hood, Martin H. Pedersen, Thomas P. Conrads, Guisong Wang, Martin Bak, Carla L. Alves and Puay Leng Lee. Their work appears in journals such as Nature Communications, International Journal of Cancer, Stem Cells, Frontiers in Oncology and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.